Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chlamydia Infections | 44 | 2023 | 196 | 11.980 |
Why?
|
Chlamydia muridarum | 31 | 2023 | 104 | 8.610 |
Why?
|
Bacterial Vaccines | 28 | 2017 | 125 | 7.470 |
Why?
|
Francisella tularensis | 26 | 2017 | 115 | 6.650 |
Why?
|
Tularemia | 26 | 2018 | 114 | 6.360 |
Why?
|
Acinetobacter baumannii | 7 | 2022 | 33 | 4.150 |
Why?
|
Interferon-gamma | 33 | 2021 | 250 | 3.980 |
Why?
|
Mast Cells | 8 | 2016 | 81 | 3.310 |
Why?
|
Endopeptidases | 11 | 2018 | 59 | 2.910 |
Why?
|
Mice | 81 | 2023 | 5913 | 2.880 |
Why?
|
Antibodies, Bacterial | 19 | 2017 | 109 | 2.820 |
Why?
|
Genital Diseases, Female | 8 | 2013 | 37 | 2.680 |
Why?
|
Thioredoxins | 4 | 2021 | 42 | 2.660 |
Why?
|
Macrophages | 16 | 2023 | 439 | 2.530 |
Why?
|
Mice, Inbred C57BL | 43 | 2023 | 1609 | 2.490 |
Why?
|
MicroRNAs | 6 | 2021 | 426 | 2.480 |
Why?
|
Lung | 15 | 2021 | 446 | 2.470 |
Why?
|
Animals | 103 | 2023 | 15081 | 2.390 |
Why?
|
CD4-Positive T-Lymphocytes | 10 | 2019 | 259 | 2.070 |
Why?
|
Mice, Inbred BALB C | 34 | 2019 | 661 | 2.050 |
Why?
|
Interleukin-12 | 15 | 2016 | 47 | 2.040 |
Why?
|
Chlamydia trachomatis | 11 | 2023 | 68 | 2.000 |
Why?
|
Bacterial Proteins | 15 | 2019 | 540 | 1.990 |
Why?
|
Antigens, Bacterial | 9 | 2014 | 132 | 1.950 |
Why?
|
Genitalia, Female | 6 | 2021 | 26 | 1.880 |
Why?
|
Virulence Factors | 7 | 2021 | 113 | 1.740 |
Why?
|
Vaccines, Attenuated | 9 | 2017 | 72 | 1.600 |
Why?
|
Acinetobacter Infections | 4 | 2021 | 22 | 1.600 |
Why?
|
Adjuvants, Immunologic | 13 | 2011 | 107 | 1.600 |
Why?
|
Administration, Intranasal | 19 | 2014 | 79 | 1.480 |
Why?
|
Immunoglobulin A | 7 | 2022 | 58 | 1.470 |
Why?
|
Bacterial Outer Membrane Proteins | 4 | 2021 | 52 | 1.410 |
Why?
|
Interleukin-4 | 6 | 2018 | 72 | 1.400 |
Why?
|
Sepsis | 5 | 2019 | 80 | 1.280 |
Why?
|
Vaccination | 11 | 2017 | 288 | 1.280 |
Why?
|
Mice, Knockout | 20 | 2016 | 933 | 1.210 |
Why?
|
Gastrointestinal Tract | 5 | 2021 | 61 | 1.190 |
Why?
|
Host-Pathogen Interactions | 10 | 2021 | 186 | 1.120 |
Why?
|
Immunoglobulin A, Secretory | 3 | 2018 | 16 | 1.100 |
Why?
|
C-Reactive Protein | 3 | 2017 | 149 | 1.100 |
Why?
|
Phagosomes | 3 | 2018 | 30 | 1.090 |
Why?
|
Immunization | 7 | 2016 | 92 | 1.090 |
Why?
|
Francisella | 3 | 2012 | 19 | 1.080 |
Why?
|
Receptors, IgE | 3 | 2016 | 23 | 1.060 |
Why?
|
Bacterial Infections | 2 | 2018 | 43 | 1.040 |
Why?
|
Female | 53 | 2023 | 20969 | 0.990 |
Why?
|
Whole Body Imaging | 2 | 2014 | 25 | 0.980 |
Why?
|
Spleen | 13 | 2017 | 199 | 0.980 |
Why?
|
Fallopian Tubes | 4 | 2013 | 17 | 0.910 |
Why?
|
Pneumonia, Bacterial | 4 | 2013 | 22 | 0.890 |
Why?
|
HLA-DR4 Antigen | 3 | 2013 | 20 | 0.890 |
Why?
|
Genitalia | 3 | 2018 | 17 | 0.880 |
Why?
|
Animals, Newborn | 7 | 2016 | 343 | 0.860 |
Why?
|
Tumor Necrosis Factor-alpha | 5 | 2013 | 356 | 0.860 |
Why?
|
Cross Infection | 1 | 2022 | 38 | 0.840 |
Why?
|
Cells, Cultured | 16 | 2018 | 1518 | 0.830 |
Why?
|
Immunity, Innate | 8 | 2021 | 149 | 0.830 |
Why?
|
Immunity, Humoral | 1 | 2022 | 24 | 0.820 |
Why?
|
Hela Cells | 15 | 2023 | 366 | 0.800 |
Why?
|
Th1 Cells | 9 | 2019 | 92 | 0.790 |
Why?
|
Humans | 50 | 2023 | 37093 | 0.780 |
Why?
|
Epitopes, T-Lymphocyte | 2 | 2013 | 57 | 0.750 |
Why?
|
Immunologic Factors | 2 | 2018 | 45 | 0.740 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2021 | 159 | 0.730 |
Why?
|
Serum Amyloid P-Component | 2 | 2017 | 20 | 0.700 |
Why?
|
Caspase 1 | 2 | 2016 | 15 | 0.700 |
Why?
|
Oligodeoxyribonucleotides | 5 | 2016 | 52 | 0.690 |
Why?
|
Fimbriae, Bacterial | 1 | 2019 | 23 | 0.690 |
Why?
|
Gene Deletion | 4 | 2018 | 166 | 0.680 |
Why?
|
Chlamydia | 4 | 2021 | 42 | 0.660 |
Why?
|
Bacterial Adhesion | 2 | 2018 | 37 | 0.650 |
Why?
|
Intestines | 3 | 2016 | 64 | 0.650 |
Why?
|
Rats, Inbred F344 | 5 | 2017 | 245 | 0.630 |
Why?
|
Chlamydophila pneumoniae | 2 | 2015 | 8 | 0.630 |
Why?
|
Respiratory Tract Infections | 2 | 2016 | 33 | 0.620 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2017 | 22 | 0.600 |
Why?
|
Gram-Negative Bacteria | 1 | 2017 | 22 | 0.600 |
Why?
|
Cytoplasmic Vesicles | 1 | 2016 | 10 | 0.570 |
Why?
|
Coculture Techniques | 5 | 2016 | 101 | 0.560 |
Why?
|
Gene Expression Regulation | 10 | 2020 | 1015 | 0.560 |
Why?
|
Bone Marrow Cells | 3 | 2012 | 81 | 0.560 |
Why?
|
Orthomyxoviridae Infections | 3 | 2001 | 12 | 0.550 |
Why?
|
Immunity | 4 | 2021 | 53 | 0.550 |
Why?
|
Disease Models, Animal | 9 | 2021 | 1371 | 0.550 |
Why?
|
Up-Regulation | 2 | 2016 | 513 | 0.540 |
Why?
|
Immunoglobulin G | 10 | 2022 | 237 | 0.530 |
Why?
|
Granzymes | 2 | 2013 | 16 | 0.530 |
Why?
|
Perforin | 2 | 2012 | 10 | 0.520 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2015 | 56 | 0.510 |
Why?
|
Influenza Vaccines | 3 | 2001 | 55 | 0.510 |
Why?
|
Insulin-Secreting Cells | 1 | 2015 | 28 | 0.500 |
Why?
|
Colony Count, Microbial | 6 | 2020 | 66 | 0.500 |
Why?
|
Toll-Like Receptor 5 | 1 | 2014 | 6 | 0.490 |
Why?
|
Immunity, Mucosal | 4 | 2017 | 47 | 0.490 |
Why?
|
Vagina | 7 | 2013 | 81 | 0.490 |
Why?
|
Flagellin | 1 | 2014 | 16 | 0.490 |
Why?
|
Shock, Septic | 1 | 2014 | 20 | 0.480 |
Why?
|
Recombinant Proteins | 5 | 2021 | 515 | 0.470 |
Why?
|
Survival Analysis | 6 | 2018 | 325 | 0.470 |
Why?
|
Plasmids | 4 | 2020 | 246 | 0.450 |
Why?
|
Down-Regulation | 1 | 2015 | 435 | 0.450 |
Why?
|
Adenosine Triphosphate | 2 | 2012 | 196 | 0.450 |
Why?
|
Receptors, Pattern Recognition | 1 | 2013 | 11 | 0.440 |
Why?
|
Cystatins | 3 | 2019 | 19 | 0.440 |
Why?
|
Immunotherapy, Adoptive | 1 | 2013 | 16 | 0.440 |
Why?
|
Genomic Islands | 2 | 2009 | 14 | 0.440 |
Why?
|
Anti-Bacterial Agents | 6 | 2018 | 352 | 0.440 |
Why?
|
Alkaline Phosphatase | 1 | 2012 | 50 | 0.430 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2012 | 47 | 0.420 |
Why?
|
Bacteremia | 1 | 2012 | 30 | 0.420 |
Why?
|
Signal Transduction | 6 | 2018 | 1908 | 0.420 |
Why?
|
Mucous Membrane | 1 | 2012 | 34 | 0.420 |
Why?
|
Toll-Like Receptor 2 | 1 | 2012 | 27 | 0.410 |
Why?
|
alpha 1-Antitrypsin | 1 | 2011 | 7 | 0.410 |
Why?
|
Gene Expression Profiling | 2 | 2016 | 626 | 0.410 |
Why?
|
Antibodies, Viral | 4 | 2022 | 262 | 0.410 |
Why?
|
Nerve Tissue Proteins | 1 | 2014 | 360 | 0.400 |
Why?
|
Adoptive Transfer | 6 | 2021 | 48 | 0.400 |
Why?
|
Respiratory System | 1 | 2011 | 28 | 0.390 |
Why?
|
Influenza A virus | 4 | 2009 | 27 | 0.390 |
Why?
|
Virulence | 8 | 2021 | 223 | 0.390 |
Why?
|
Mannose | 1 | 2011 | 25 | 0.390 |
Why?
|
Oligosaccharides | 1 | 2011 | 24 | 0.380 |
Why?
|
Vibrio cholerae | 2 | 2011 | 98 | 0.380 |
Why?
|
Infertility, Female | 1 | 2011 | 24 | 0.380 |
Why?
|
Guinea Pigs | 3 | 2016 | 145 | 0.380 |
Why?
|
Immunization, Passive | 3 | 2022 | 19 | 0.370 |
Why?
|
Sexually Transmitted Diseases, Bacterial | 1 | 2009 | 7 | 0.360 |
Why?
|
Cytokines | 9 | 2018 | 602 | 0.350 |
Why?
|
Intestinal Mucosa | 2 | 2011 | 122 | 0.350 |
Why?
|
Interleukin-17 | 3 | 2016 | 53 | 0.350 |
Why?
|
Disease Susceptibility | 1 | 2010 | 97 | 0.350 |
Why?
|
T-Lymphocytes | 3 | 2009 | 357 | 0.330 |
Why?
|
Lymphocytes | 3 | 2021 | 118 | 0.330 |
Why?
|
Neutrophils | 3 | 2015 | 131 | 0.330 |
Why?
|
Biofilms | 1 | 2011 | 168 | 0.330 |
Why?
|
Contact Inhibition | 1 | 2008 | 4 | 0.330 |
Why?
|
Vaginal Diseases | 1 | 2008 | 9 | 0.320 |
Why?
|
Antibodies, Neutralizing | 2 | 2022 | 109 | 0.310 |
Why?
|
Colon | 2 | 2021 | 103 | 0.310 |
Why?
|
Chemokines | 2 | 2021 | 97 | 0.300 |
Why?
|
DNA Replication | 1 | 2008 | 152 | 0.300 |
Why?
|
Leukocytes, Mononuclear | 3 | 2018 | 234 | 0.300 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2015 | 643 | 0.300 |
Why?
|
Receptors, Polymeric Immunoglobulin | 1 | 2006 | 2 | 0.290 |
Why?
|
Cervix Uteri | 2 | 2019 | 42 | 0.280 |
Why?
|
IgA Deficiency | 2 | 2009 | 6 | 0.280 |
Why?
|
Aging | 1 | 2011 | 664 | 0.280 |
Why?
|
Antibodies, Monoclonal | 2 | 2022 | 290 | 0.280 |
Why?
|
Lymphocyte Activation | 4 | 2016 | 236 | 0.270 |
Why?
|
Antigens, Surface | 3 | 2001 | 43 | 0.270 |
Why?
|
Inflammation | 4 | 2023 | 618 | 0.270 |
Why?
|
Chaperonin 60 | 2 | 2018 | 18 | 0.270 |
Why?
|
Osteoblasts | 4 | 2012 | 35 | 0.270 |
Why?
|
Colitis | 1 | 2006 | 65 | 0.270 |
Why?
|
Administration, Oral | 3 | 2012 | 224 | 0.260 |
Why?
|
Vaccines, Synthetic | 3 | 2010 | 72 | 0.260 |
Why?
|
Cell Line | 4 | 2014 | 1354 | 0.260 |
Why?
|
Models, Animal | 4 | 2017 | 134 | 0.260 |
Why?
|
Microscopy, Confocal | 2 | 2016 | 218 | 0.260 |
Why?
|
Phagocytosis | 5 | 2013 | 69 | 0.250 |
Why?
|
Mice, Transgenic | 4 | 2013 | 617 | 0.240 |
Why?
|
Immunity, Cellular | 2 | 2008 | 70 | 0.240 |
Why?
|
Cell Communication | 2 | 2016 | 97 | 0.240 |
Why?
|
Antibody Formation | 4 | 2013 | 74 | 0.230 |
Why?
|
Protein Transport | 2 | 2016 | 302 | 0.230 |
Why?
|
Species Specificity | 2 | 2014 | 245 | 0.220 |
Why?
|
Antigen Presentation | 2 | 2016 | 54 | 0.220 |
Why?
|
Bacteria | 2 | 2019 | 255 | 0.210 |
Why?
|
Acid Phosphatase | 2 | 2021 | 21 | 0.210 |
Why?
|
Caspase 3 | 2 | 2015 | 207 | 0.210 |
Why?
|
Carcinoma | 1 | 2023 | 96 | 0.210 |
Why?
|
Income | 1 | 2023 | 140 | 0.210 |
Why?
|
Cystatin C | 2 | 2019 | 24 | 0.200 |
Why?
|
Pneumococcal Infections | 1 | 2001 | 29 | 0.200 |
Why?
|
Immunoglobulin M | 3 | 2017 | 82 | 0.200 |
Why?
|
Klebsiella pneumoniae | 2 | 2019 | 17 | 0.200 |
Why?
|
Membrane Glycoproteins | 1 | 2023 | 211 | 0.200 |
Why?
|
Immunomodulation | 2 | 2019 | 15 | 0.190 |
Why?
|
Immunity, Active | 2 | 2013 | 6 | 0.190 |
Why?
|
Pertussis Toxin | 2 | 2011 | 27 | 0.190 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2001 | 42 | 0.190 |
Why?
|
Genes, MHC Class I | 2 | 2012 | 13 | 0.190 |
Why?
|
Genes, MHC Class II | 2 | 2012 | 20 | 0.180 |
Why?
|
Monocytes | 2 | 2014 | 257 | 0.180 |
Why?
|
Cell Death | 2 | 2012 | 267 | 0.180 |
Why?
|
Intestine, Small | 2 | 2019 | 25 | 0.180 |
Why?
|
Osteogenesis | 3 | 2012 | 35 | 0.180 |
Why?
|
Oviducts | 3 | 2013 | 13 | 0.180 |
Why?
|
Proteome | 1 | 2021 | 144 | 0.180 |
Why?
|
beta-Lactamases | 2 | 2018 | 33 | 0.170 |
Why?
|
Infertility | 1 | 2019 | 18 | 0.170 |
Why?
|
Intestine, Large | 1 | 2019 | 5 | 0.170 |
Why?
|
Refrigeration | 1 | 2019 | 4 | 0.170 |
Why?
|
Blood Preservation | 1 | 2019 | 6 | 0.170 |
Why?
|
Disinfection | 1 | 2019 | 9 | 0.170 |
Why?
|
Rats | 7 | 2017 | 3483 | 0.170 |
Why?
|
Nasal Mucosa | 1 | 1999 | 29 | 0.170 |
Why?
|
Lymphocyte Depletion | 2 | 2009 | 13 | 0.160 |
Why?
|
Host-Parasite Interactions | 2 | 2017 | 42 | 0.160 |
Why?
|
B-Lymphocytes | 2 | 2016 | 185 | 0.160 |
Why?
|
Blood Platelets | 1 | 2019 | 77 | 0.160 |
Why?
|
Genome, Bacterial | 2 | 2020 | 114 | 0.160 |
Why?
|
Hemagglutinin Glycoproteins, Influenza Virus | 3 | 2011 | 15 | 0.160 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2019 | 149 | 0.160 |
Why?
|
Hydrogen-Ion Concentration | 2 | 2021 | 364 | 0.160 |
Why?
|
Klebsiella Infections | 1 | 2018 | 7 | 0.160 |
Why?
|
Mycobacterium bovis | 1 | 2018 | 15 | 0.160 |
Why?
|
Immune Evasion | 1 | 2018 | 16 | 0.160 |
Why?
|
Mycobacterium Infections | 1 | 2018 | 16 | 0.160 |
Why?
|
Endosomes | 1 | 2018 | 36 | 0.160 |
Why?
|
Electric Stimulation | 2 | 2012 | 184 | 0.160 |
Why?
|
Molecular Weight | 2 | 2021 | 167 | 0.150 |
Why?
|
Tissue Engineering | 2 | 2012 | 60 | 0.150 |
Why?
|
Cell Polarity | 1 | 2018 | 54 | 0.150 |
Why?
|
Intubation, Intratracheal | 1 | 2017 | 19 | 0.150 |
Why?
|
Neutrophil Infiltration | 2 | 2015 | 27 | 0.150 |
Why?
|
Urogenital System | 1 | 2017 | 2 | 0.150 |
Why?
|
Adaptive Immunity | 1 | 2017 | 27 | 0.150 |
Why?
|
Disease Progression | 1 | 2020 | 601 | 0.150 |
Why?
|
Vaccines, Subunit | 2 | 2007 | 30 | 0.150 |
Why?
|
Immunoglobulin Class Switching | 1 | 2017 | 19 | 0.150 |
Why?
|
Genetic Predisposition to Disease | 1 | 2001 | 628 | 0.150 |
Why?
|
Influenza B virus | 2 | 2007 | 5 | 0.150 |
Why?
|
Oxidation-Reduction | 1 | 2018 | 431 | 0.140 |
Why?
|
Cell Surface Extensions | 1 | 2016 | 7 | 0.140 |
Why?
|
Transfection | 1 | 2018 | 523 | 0.140 |
Why?
|
Cell Differentiation | 2 | 2017 | 587 | 0.140 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2016 | 18 | 0.140 |
Why?
|
Pulmonary Surfactant-Associated Protein A | 1 | 2016 | 4 | 0.140 |
Why?
|
Mutagenesis, Insertional | 2 | 2008 | 32 | 0.140 |
Why?
|
DNA, Bacterial | 3 | 2019 | 186 | 0.140 |
Why?
|
Respiratory Hypersensitivity | 1 | 2016 | 16 | 0.140 |
Why?
|
Immunologic Memory | 3 | 2001 | 38 | 0.130 |
Why?
|
Respiratory Function Tests | 1 | 2016 | 55 | 0.130 |
Why?
|
Interleukin-2 | 1 | 2016 | 89 | 0.130 |
Why?
|
Nitric Oxide | 1 | 2018 | 316 | 0.130 |
Why?
|
Specific Pathogen-Free Organisms | 1 | 2015 | 20 | 0.130 |
Why?
|
Genes, Bacterial | 3 | 2011 | 90 | 0.130 |
Why?
|
Receptors, IgG | 2 | 2008 | 50 | 0.130 |
Why?
|
Mice, Obese | 1 | 2015 | 40 | 0.130 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2015 | 142 | 0.130 |
Why?
|
Immunodominant Epitopes | 1 | 2014 | 27 | 0.120 |
Why?
|
RNA, Messenger | 5 | 2004 | 1207 | 0.120 |
Why?
|
Interleukin-1beta | 1 | 2015 | 70 | 0.120 |
Why?
|
Obesity | 1 | 2023 | 1067 | 0.120 |
Why?
|
Body Fluids | 1 | 2014 | 17 | 0.120 |
Why?
|
Macrophages, Alveolar | 2 | 2013 | 34 | 0.120 |
Why?
|
Molecular Imaging | 1 | 2014 | 30 | 0.120 |
Why?
|
RNA, Small Interfering | 1 | 2016 | 409 | 0.120 |
Why?
|
Cross Reactions | 3 | 2013 | 83 | 0.120 |
Why?
|
Fluorescence | 1 | 2014 | 121 | 0.120 |
Why?
|
Pseudomonas aeruginosa | 2 | 2012 | 57 | 0.120 |
Why?
|
Peroxidase | 1 | 2014 | 49 | 0.120 |
Why?
|
Chickens | 2 | 2009 | 133 | 0.120 |
Why?
|
Fallopian Tube Diseases | 1 | 2013 | 1 | 0.120 |
Why?
|
Drug Therapy, Combination | 2 | 2007 | 227 | 0.120 |
Why?
|
Flow Cytometry | 1 | 2015 | 399 | 0.120 |
Why?
|
Adult | 4 | 2023 | 11712 | 0.110 |
Why?
|
Bacterial Shedding | 1 | 2013 | 3 | 0.110 |
Why?
|
Cell Degranulation | 1 | 2013 | 11 | 0.110 |
Why?
|
Ligands | 1 | 2014 | 349 | 0.110 |
Why?
|
Mice, SCID | 2 | 2011 | 150 | 0.110 |
Why?
|
Chromatography, DEAE-Cellulose | 1 | 2012 | 8 | 0.110 |
Why?
|
Microbial Viability | 2 | 2009 | 37 | 0.110 |
Why?
|
Killer Cells, Natural | 2 | 2007 | 92 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2012 | 14 | 0.110 |
Why?
|
Receptors, Cell Surface | 2 | 2010 | 144 | 0.110 |
Why?
|
Norepinephrine | 3 | 1997 | 110 | 0.110 |
Why?
|
Major Histocompatibility Complex | 1 | 2012 | 21 | 0.110 |
Why?
|
Transforming Growth Factor beta | 2 | 2004 | 197 | 0.100 |
Why?
|
Mesenchymal Stem Cells | 1 | 2012 | 62 | 0.100 |
Why?
|
Mechanotransduction, Cellular | 2 | 2003 | 48 | 0.100 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2012 | 47 | 0.100 |
Why?
|
Proteinase Inhibitory Proteins, Secretory | 1 | 2011 | 3 | 0.100 |
Why?
|
Leukocyte Elastase | 1 | 2011 | 9 | 0.100 |
Why?
|
Haptoglobins | 1 | 2011 | 10 | 0.100 |
Why?
|
Mice, Inbred CBA | 3 | 2021 | 38 | 0.100 |
Why?
|
Liver | 1 | 2015 | 479 | 0.100 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 623 | 0.100 |
Why?
|
Toll-Like Receptor 4 | 1 | 2012 | 62 | 0.100 |
Why?
|
Time Factors | 4 | 2019 | 1742 | 0.100 |
Why?
|
Lung Compliance | 1 | 2011 | 3 | 0.100 |
Why?
|
Cell Survival | 1 | 2015 | 864 | 0.100 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2012 | 132 | 0.100 |
Why?
|
Erythromycin | 1 | 2011 | 13 | 0.100 |
Why?
|
Bronchial Hyperreactivity | 1 | 2011 | 12 | 0.100 |
Why?
|
Recombinant Fusion Proteins | 2 | 2010 | 295 | 0.100 |
Why?
|
Asthma | 1 | 2016 | 380 | 0.100 |
Why?
|
Pulmonary Alveoli | 1 | 2011 | 27 | 0.100 |
Why?
|
Pregnancy | 3 | 2023 | 1549 | 0.100 |
Why?
|
Cloaca | 1 | 2011 | 4 | 0.100 |
Why?
|
Orthomyxoviridae | 1 | 2011 | 5 | 0.100 |
Why?
|
Ducks | 1 | 2011 | 8 | 0.100 |
Why?
|
Polymyxin B | 1 | 2011 | 8 | 0.100 |
Why?
|
Genetic Complementation Test | 1 | 2011 | 59 | 0.100 |
Why?
|
Aged | 1 | 2023 | 6741 | 0.100 |
Why?
|
Integrin alpha4beta1 | 1 | 2011 | 5 | 0.100 |
Why?
|
Drug Administration Schedule | 1 | 2011 | 143 | 0.100 |
Why?
|
Nitrites | 1 | 2011 | 46 | 0.100 |
Why?
|
Anaphylaxis | 1 | 2011 | 14 | 0.100 |
Why?
|
Receptors, Interleukin-4 | 1 | 2010 | 10 | 0.090 |
Why?
|
Milk | 1 | 2011 | 50 | 0.090 |
Why?
|
Mannose-Binding Lectins | 1 | 2010 | 14 | 0.090 |
Why?
|
Organelles | 1 | 2010 | 24 | 0.090 |
Why?
|
Survival Rate | 2 | 2009 | 311 | 0.090 |
Why?
|
Lectins, C-Type | 1 | 2010 | 36 | 0.090 |
Why?
|
Receptors, Interferon | 1 | 2010 | 14 | 0.090 |
Why?
|
Mutation | 3 | 2021 | 1095 | 0.090 |
Why?
|
Cell Movement | 2 | 2013 | 571 | 0.090 |
Why?
|
Tryptophan | 1 | 2011 | 73 | 0.090 |
Why?
|
Encephalomyelitis, Autoimmune, Experimental | 1 | 2011 | 54 | 0.090 |
Why?
|
Interleukin-10 | 2 | 2001 | 75 | 0.090 |
Why?
|
Peptide Fragments | 1 | 2012 | 308 | 0.090 |
Why?
|
Lymphogranuloma Venereum | 1 | 2010 | 5 | 0.090 |
Why?
|
Vaccines, Inactivated | 1 | 2010 | 14 | 0.090 |
Why?
|
Oligopeptides | 1 | 2010 | 102 | 0.090 |
Why?
|
Protein Denaturation | 1 | 2010 | 43 | 0.090 |
Why?
|
Cricetinae | 1 | 2010 | 238 | 0.090 |
Why?
|
Influenza in Birds | 1 | 2009 | 8 | 0.090 |
Why?
|
Phenotype | 1 | 2012 | 689 | 0.090 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2009 | 16 | 0.090 |
Why?
|
Enzyme Activation | 1 | 2010 | 444 | 0.090 |
Why?
|
Hot Temperature | 1 | 2010 | 128 | 0.080 |
Why?
|
Protein Binding | 1 | 2012 | 972 | 0.080 |
Why?
|
Membrane Transport Proteins | 1 | 2009 | 95 | 0.080 |
Why?
|
Gene Expression | 3 | 2002 | 674 | 0.080 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 448 | 0.080 |
Why?
|
Influenza, Human | 2 | 2007 | 83 | 0.080 |
Why?
|
Intracellular Space | 1 | 2008 | 35 | 0.080 |
Why?
|
beta 2-Microglobulin | 1 | 2008 | 10 | 0.080 |
Why?
|
Bacterial Toxins | 3 | 1997 | 44 | 0.080 |
Why?
|
Malaysia | 2 | 2019 | 8 | 0.080 |
Why?
|
Enzyme Inhibitors | 1 | 2010 | 433 | 0.080 |
Why?
|
Alleles | 2 | 2006 | 321 | 0.080 |
Why?
|
Gene Targeting | 1 | 2008 | 38 | 0.080 |
Why?
|
Introns | 1 | 2008 | 75 | 0.080 |
Why?
|
Microbial Sensitivity Tests | 2 | 2019 | 201 | 0.080 |
Why?
|
Immunotherapy | 2 | 2019 | 95 | 0.070 |
Why?
|
Computational Biology | 1 | 2009 | 293 | 0.070 |
Why?
|
Cell Adhesion | 1 | 2008 | 212 | 0.070 |
Why?
|
Epitopes | 1 | 2007 | 148 | 0.070 |
Why?
|
Interleukin-15 | 1 | 2007 | 13 | 0.070 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2006 | 56 | 0.070 |
Why?
|
CpG Islands | 1 | 2007 | 97 | 0.070 |
Why?
|
Female Urogenital Diseases | 1 | 2006 | 2 | 0.070 |
Why?
|
Escherichia coli O157 | 2 | 1997 | 16 | 0.070 |
Why?
|
Body Weight | 1 | 2009 | 434 | 0.070 |
Why?
|
Dextran Sulfate | 1 | 2006 | 15 | 0.070 |
Why?
|
Inclusion Bodies | 1 | 2006 | 33 | 0.070 |
Why?
|
Biosensing Techniques | 1 | 2008 | 86 | 0.070 |
Why?
|
Occult Blood | 1 | 2006 | 29 | 0.070 |
Why?
|
Phosphoproteins | 1 | 2007 | 163 | 0.070 |
Why?
|
Fluorescent Antibody Technique | 1 | 2006 | 189 | 0.070 |
Why?
|
Gentamicins | 1 | 2004 | 10 | 0.060 |
Why?
|
Base Sequence | 3 | 2007 | 997 | 0.060 |
Why?
|
Amoeba | 1 | 2004 | 6 | 0.060 |
Why?
|
Streptococcus pneumoniae | 2 | 2001 | 30 | 0.060 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2005 | 114 | 0.060 |
Why?
|
Pneumococcal Vaccines | 2 | 2001 | 14 | 0.060 |
Why?
|
Escherichia coli | 2 | 1997 | 453 | 0.060 |
Why?
|
Osteocalcin | 1 | 2003 | 4 | 0.060 |
Why?
|
Physical Stimulation | 1 | 2003 | 26 | 0.060 |
Why?
|
Cohort Studies | 2 | 2019 | 1492 | 0.060 |
Why?
|
Calcium | 2 | 2003 | 480 | 0.060 |
Why?
|
Cell Line, Tumor | 2 | 2021 | 2231 | 0.050 |
Why?
|
Bone Resorption | 1 | 2002 | 8 | 0.050 |
Why?
|
Collagen | 1 | 2003 | 172 | 0.050 |
Why?
|
Sequence Analysis, DNA | 3 | 2011 | 474 | 0.050 |
Why?
|
Osteoclasts | 1 | 2002 | 14 | 0.050 |
Why?
|
Dinitrophenols | 2 | 1999 | 6 | 0.050 |
Why?
|
Composite Resins | 1 | 2002 | 2 | 0.050 |
Why?
|
Polymerase Chain Reaction | 1 | 2003 | 448 | 0.050 |
Why?
|
Ovalbumin | 2 | 1999 | 47 | 0.050 |
Why?
|
Electric Conductivity | 1 | 2002 | 51 | 0.050 |
Why?
|
DNA Primers | 2 | 2001 | 286 | 0.050 |
Why?
|
Proteomics | 2 | 2016 | 325 | 0.050 |
Why?
|
Sequence Homology | 1 | 2021 | 34 | 0.050 |
Why?
|
Glutathione Transferase | 2 | 2016 | 88 | 0.050 |
Why?
|
Lymphocyte Transfusion | 1 | 2021 | 2 | 0.050 |
Why?
|
Hydrolysis | 1 | 2021 | 99 | 0.050 |
Why?
|
Meningococcal Vaccines | 1 | 2001 | 7 | 0.050 |
Why?
|
HN Protein | 1 | 2001 | 1 | 0.050 |
Why?
|
Molecular Sequence Data | 3 | 2011 | 1568 | 0.050 |
Why?
|
Lymphoproliferative Disorders | 1 | 2001 | 10 | 0.050 |
Why?
|
HIV-1 | 1 | 2007 | 706 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2006 | 1198 | 0.050 |
Why?
|
Substrate Specificity | 1 | 2021 | 212 | 0.050 |
Why?
|
Male | 4 | 2015 | 20025 | 0.050 |
Why?
|
Immunoglobulin Isotypes | 1 | 2000 | 16 | 0.050 |
Why?
|
Injections, Intraperitoneal | 1 | 2000 | 60 | 0.050 |
Why?
|
Th2 Cells | 1 | 2000 | 58 | 0.040 |
Why?
|
Bacteria, Anaerobic | 1 | 2019 | 10 | 0.040 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2019 | 13 | 0.040 |
Why?
|
Neuraminidase | 1 | 1999 | 9 | 0.040 |
Why?
|
Metagenomics | 1 | 2019 | 34 | 0.040 |
Why?
|
Organ Specificity | 1 | 2020 | 129 | 0.040 |
Why?
|
Epithelial Cells | 1 | 2023 | 384 | 0.040 |
Why?
|
Kinetics | 1 | 2021 | 708 | 0.040 |
Why?
|
Lipopolysaccharides | 1 | 2001 | 220 | 0.040 |
Why?
|
Academic Medical Centers | 1 | 2019 | 60 | 0.040 |
Why?
|
Serum Amyloid A Protein | 1 | 2019 | 14 | 0.040 |
Why?
|
Interleukins | 1 | 2019 | 29 | 0.040 |
Why?
|
Antigens, T-Independent | 1 | 1998 | 1 | 0.040 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2019 | 171 | 0.040 |
Why?
|
Polysaccharides, Bacterial | 1 | 1998 | 12 | 0.040 |
Why?
|
Muramidase | 1 | 1999 | 22 | 0.040 |
Why?
|
Antigens | 1 | 1999 | 56 | 0.040 |
Why?
|
Young Adult | 2 | 2019 | 4268 | 0.040 |
Why?
|
Immune Tolerance | 1 | 1999 | 65 | 0.040 |
Why?
|
Feces | 1 | 1999 | 111 | 0.040 |
Why?
|
Amino Acid Sequence | 1 | 2021 | 1180 | 0.040 |
Why?
|
Genotype | 1 | 2021 | 730 | 0.040 |
Why?
|
Genetic Variation | 1 | 2021 | 387 | 0.040 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2018 | 30 | 0.040 |
Why?
|
Inflammation Mediators | 1 | 2018 | 123 | 0.040 |
Why?
|
Adhesins, Bacterial | 1 | 1997 | 20 | 0.040 |
Why?
|
Sympathomimetics | 1 | 1996 | 8 | 0.040 |
Why?
|
Neurosecretory Systems | 1 | 1996 | 16 | 0.040 |
Why?
|
Gynecology | 1 | 2016 | 31 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2016 | 67 | 0.030 |
Why?
|
Staining and Labeling | 1 | 2016 | 105 | 0.030 |
Why?
|
Obstetrics | 1 | 2016 | 37 | 0.030 |
Why?
|
Cell Division | 3 | 2002 | 307 | 0.030 |
Why?
|
RNA, Viral | 2 | 2007 | 301 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2016 | 142 | 0.030 |
Why?
|
Macaca fascicularis | 1 | 2014 | 64 | 0.030 |
Why?
|
Tandem Mass Spectrometry | 1 | 2016 | 182 | 0.030 |
Why?
|
H-2 Antigens | 1 | 2014 | 4 | 0.030 |
Why?
|
Luciferases | 1 | 2014 | 63 | 0.030 |
Why?
|
Mice, Inbred DBA | 1 | 2013 | 71 | 0.030 |
Why?
|
Haplotypes | 1 | 2014 | 182 | 0.030 |
Why?
|
Rats, Sprague-Dawley | 3 | 2003 | 1618 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2007 | 562 | 0.030 |
Why?
|
Electromagnetic Fields | 1 | 2012 | 8 | 0.030 |
Why?
|
Pressure | 2 | 2003 | 43 | 0.030 |
Why?
|
HIV Infections | 1 | 2007 | 2303 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2012 | 37 | 0.030 |
Why?
|
Ciprofloxacin | 1 | 2012 | 14 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2012 | 146 | 0.020 |
Why?
|
Lipase | 1 | 2011 | 18 | 0.020 |
Why?
|
Prevalence | 1 | 2016 | 1455 | 0.020 |
Why?
|
Antibodies, Blocking | 1 | 2011 | 11 | 0.020 |
Why?
|
Myelin-Associated Glycoprotein | 1 | 2011 | 17 | 0.020 |
Why?
|
Myelin Proteins | 1 | 2011 | 26 | 0.020 |
Why?
|
History, 21st Century | 1 | 2011 | 81 | 0.020 |
Why?
|
Drug Combinations | 1 | 2011 | 98 | 0.020 |
Why?
|
Multigene Family | 1 | 2009 | 106 | 0.020 |
Why?
|
Peptide Hydrolases | 1 | 2009 | 40 | 0.020 |
Why?
|
Spain | 1 | 2008 | 36 | 0.020 |
Why?
|
Molecular Imprinting | 1 | 2008 | 2 | 0.020 |
Why?
|
Enzymes | 1 | 2008 | 32 | 0.020 |
Why?
|
Aptamers, Nucleotide | 1 | 2008 | 31 | 0.020 |
Why?
|
Genetic Vectors | 1 | 2008 | 158 | 0.020 |
Why?
|
Antibodies | 1 | 2008 | 141 | 0.020 |
Why?
|
Normetanephrine | 2 | 1997 | 3 | 0.020 |
Why?
|
Pan troglodytes | 1 | 2007 | 21 | 0.020 |
Why?
|
Shiga Toxin 1 | 2 | 1997 | 3 | 0.020 |
Why?
|
Intracellular Membranes | 1 | 2006 | 38 | 0.020 |
Why?
|
Nepal | 1 | 2006 | 15 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2006 | 195 | 0.020 |
Why?
|
Viral Load | 1 | 2007 | 312 | 0.020 |
Why?
|
Viral Proteins | 1 | 2006 | 174 | 0.020 |
Why?
|
Ampicillin Resistance | 1 | 2003 | 3 | 0.010 |
Why?
|
Recombinases | 1 | 2003 | 3 | 0.010 |
Why?
|
DNA Transposable Elements | 1 | 2003 | 48 | 0.010 |
Why?
|
Periodicity | 1 | 2003 | 34 | 0.010 |
Why?
|
Collagen Type I | 1 | 2003 | 30 | 0.010 |
Why?
|
Duodenum | 1 | 2003 | 12 | 0.010 |
Why?
|
Injections, Subcutaneous | 1 | 2003 | 33 | 0.010 |
Why?
|
Chronic Disease | 1 | 2007 | 484 | 0.010 |
Why?
|
Equipment Design | 1 | 2003 | 124 | 0.010 |
Why?
|
Mice, Inbred C3H | 1 | 2003 | 84 | 0.010 |
Why?
|
Phylogeny | 1 | 2006 | 644 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2003 | 142 | 0.010 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2003 | 93 | 0.010 |
Why?
|
Carbon Compounds, Inorganic | 1 | 2002 | 2 | 0.010 |
Why?
|
Bone Matrix | 1 | 2002 | 5 | 0.010 |
Why?
|
Prostheses and Implants | 1 | 2002 | 15 | 0.010 |
Why?
|
Femur | 1 | 2002 | 36 | 0.010 |
Why?
|
Bone Development | 1 | 2001 | 15 | 0.010 |
Why?
|
Cell Count | 1 | 2002 | 135 | 0.010 |
Why?
|
Reference Values | 1 | 2002 | 212 | 0.010 |
Why?
|
Isoenzymes | 1 | 2002 | 161 | 0.010 |
Why?
|
Lactic Acid | 1 | 2002 | 95 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2005 | 539 | 0.010 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 1 | 2001 | 11 | 0.010 |
Why?
|
Vaccines, Conjugate | 1 | 2001 | 7 | 0.010 |
Why?
|
Complement Activation | 1 | 2001 | 13 | 0.010 |
Why?
|
Stress, Mechanical | 1 | 2001 | 113 | 0.010 |
Why?
|
Extracellular Matrix | 1 | 2002 | 115 | 0.010 |
Why?
|
Elapid Venoms | 1 | 2001 | 16 | 0.010 |
Why?
|
Bone and Bones | 1 | 2001 | 86 | 0.010 |
Why?
|
Polymers | 1 | 2002 | 121 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2003 | 893 | 0.010 |
Why?
|
Erythrocytes | 1 | 2001 | 111 | 0.010 |
Why?
|
Ficoll | 1 | 1998 | 1 | 0.010 |
Why?
|
Haptens | 1 | 1998 | 20 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2002 | 935 | 0.010 |
Why?
|
Lymphopenia | 1 | 1998 | 16 | 0.010 |
Why?
|
Interferon-alpha | 1 | 1998 | 43 | 0.010 |
Why?
|
Neisseria meningitidis | 1 | 1998 | 16 | 0.010 |
Why?
|
Shiga Toxin 2 | 1 | 1997 | 3 | 0.010 |
Why?
|
Enterotoxins | 1 | 1997 | 33 | 0.010 |
Why?
|
Culture Media | 1 | 1996 | 90 | 0.010 |
Why?
|
United States | 1 | 2006 | 4223 | 0.010 |
Why?
|
Cattle | 1 | 1997 | 477 | 0.010 |
Why?
|